Captopril: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) |
||
| Line 16: | Line 16: | ||
==Prescribing Information== | ==Prescribing Information== | ||
===''[[Captopril | ===''[[Captopril]]''=== | ||
* [[Captopril]] | * [[Captopril]] | ||
===''[[Captopril and Hydrochlorothiazide | ===''[[Captopril and Hydrochlorothiazide]]''=== | ||
* [[Captopril and Hydrochlorothiazide tablet]] | * [[Captopril and Hydrochlorothiazide tablet]] | ||
==References== | ==References== | ||
Revision as of 15:44, 26 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2], Ahmed Zaghw, M.D. [3]
For patient information about Captopril, click here.
Synonyms / Brand Names: Capoten
Overview
Captopril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia(11% ), disorder of taste, cough (0.5% to 2%). hypotension, rash, hyperkalemia (11% ), disorder of taste, cough (0.5% to 2%).
Category
Antihypertensive Agents, ACE Inhibitors.
Prescribing Information
Captopril
Captopril and Hydrochlorothiazide
References
- Atkinson AB, Robertson JIS. Captopril in the treatment of hypertension and cardiac failure. Lancet 1979;2(8147):836–9. PMID 90928
- Patchett AA, Harris E, Tristam EQ, et al. A new class of angiotensin-converting enzyme inhibitors. Nature 1980;288(5788):280–3. PMID 6253826
- Rossi S, editor. Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006.
- Smith CG, Vane JR. The discovery of captopril. FASEB J 2003;17:788-9. Fulltext. PMID 12724335.